Medical Oncology/Academic Job Postings

 

Investigational New Drug Fellowship in Medical Oncology - Juravinski Cancer Centre – Hamilton, ON

Click here for more details

Original posting August 2017


Clinical Research Fellowship, Medical Oncology - McMaster University - Hamilton, ON

Click here for more details

Original posting August 2017


Clinical Research Fellowship, Malignant Hematology - McMaster University - Hamilton, ON

Click here for more details

Original posting August 2017


Medical Oncology, Locum Opportunity - BC Cancer Agency (Vancouver Island Cancer Centre) – Victoria, BC

Click here for more details

Original posting July 2017


Fellowship Program, Radiation Oncology - Juravinski Cancer Centre – Hamilton, ON

Click here for more details

Original posting June 2017


Medical Oncologist, Permanent - Saskatchewan Cancer Agency - Saskatoon, Saskatchewan

Click here for more details

Original posting June 2017


Fellowship in Breast Cancer Research - Sunnybrook Health Sciences Centre - Toronto, ON

Click here for more details

Original posting June 2017


Fellowship Positions, 4 open competition + 2 site specific (Gynecology, Sarcoma) - University of Calgary - Calgary, AB

Click here for more details

Original posting May 2017


Medical Oncologist, Regular, Full-Time - BC Cancer Agency - Vancouver, BC

Click here for more details

Original posting April 2017


Benign Hematology & Thrombosis - Walker Family Cancer Centre & Niagara Health - Niagara, ON

Click here for more details

Original posting April 2017


Radiation Oncology , Cyberknife Fellowship - Juravinski Cancer Centre – Hamilton, ON

Click here for more details

Original posting March 2017 


Medical Oncologist, APP Position - Quinte Health Care – Belleville General Hospital

Click here for more details

Original posting March 2017


Academic Radiation Oncologist - Queen's University - Kingston, Ontario

Click here for more details

Original posting February 2017


LOCUM Hematologist - Oakville Trafalgar Memorial Hospital - Oakville, Ontario

Click here for more details

Original posting February 2017


Medical Oncologist, Department of Medicine - Dalhousie University/Nova Scotia Health Authority - Halifax, Nova Scotia

Click here for more details

Original posting February 2017


Academic Medical Oncologist - Queen's University - Kingston, Ontario

Click here for more details

Original posting February 2017


Clinician Scientist in Hematology/Oncology - Juravinski Cancer Centre, Hamilton, Ontario

Click here for more details

Original posting February 2017


Academic Hematologist, Specializing in Malignant Blood Disorders - Juravinski Cancer Centre, Hamilton, Ontario

Click here for more details

Original posting February 2017


Medical Oncologist, Genito-Urinary cancers - Juravinski Cancer Centre - Hamilton, Ontario

Click here for more details

Original posting January 2017


Medical Oncologist, Breast and GI Cancers - Juravinski Cancer Centre - Hamilton, Ontario

Click here for more details

Original posting January 2017


 

OncologyEducation posts job postings for academic positions (research, fellowships, etc.) and for medical oncologist positions (or other oncologist positions) for hospitals, health networks, governmental cancer agencies, and universities/university research centres. The job posting will be available on our website free of charge for 6 months. Any other job posting or organization types will not be considered. To post a job, please contact elearning@oncologyeducation.com

Oncology Clinical News

Bristol-Myers Kidney Cancer Drug Fails Late-stage Trial

(Reuters) Aug 15, 2017 - Bristol-Myers Squibb Co said on Tuesday its combination drug to treat previously untreated patients with advanced or metastatic renal cell carcinoma, a type of kidney cancer, failed to meet one of the main goals of a late-stage trial.
Read full article.

FDA Accepts Supplemental Biologics License Application and Grants Priority Review for ADCETRIS® (Brentuximab Vedotin) in Cutaneous T-Cell Lymphoma

(Yahoo! Finance) Aug 16, 2017 - Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental Biologics License Application (BLA) based on data from the phase 3 ALCANZA trial and two phase 2 investigator-sponsored trials of ADCETRIS (brentuximab vedotin) in patients with cutaneous T-cell lymphoma (CTCL).
Read full article.

Powered by OBR Oncology